Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb;44(1):56-61.
doi: 10.1053/j.sult.2022.11.004. Epub 2022 Nov 18.

The Current State of Timeliness in the Breast Cancer Diagnosis Journey: Abnormal Screening to Biopsy

Gopal R Vijayaraghavan  1 , Isabelle M Guembou  2 , Srinivasan Vedantham  3
Affiliations
Review

The Current State of Timeliness in the Breast Cancer Diagnosis Journey: Abnormal Screening to Biopsy

Gopal R Vijayaraghavan et al. Semin Ultrasound CT MR. 2023 Feb.

Abstract

There are several steps involved in a breast cancer diagnosis, starting from the initial abnormal screening mammogram. Each step from the additional imaging to a biopsy provokes anxiety. Timely attention to these appointments will not only help allay anxiety but also provide better care. While breast facilities routinely audit their performance, currently timeliness is not one of the audit parameters. The role of timeliness as a robust quality tool is gaining attention. In this study, we review the timeline of care at our facility over a 1-year period (October 2021- September 2022) and compare them with those reported by National Quality Measures for Breast Centers (NQMBC). Race, ethnicity, location, and type of facility affect the outcome of care and contribute to delays in providing care. In this manuscript, we outline some of the major factors. Societal guidelines outlining some metrics for timeliness may be a useful first step.

Keywords: audit.; breast cancer; mammography; quality.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
System-wide, month-to-month availability of 1st and 3rd appointments and the actual time interval, between screening exam and diagnostic workup and between diagnostic workup and biopsy.
Figure 2.
Figure 2.
Month-to-month availability of 1st and 3rd appointments and the actual time interval, between screening exam and diagnostic workup and between diagnostic workup and biopsy, at the primary academic site.
See this image and copyright information in PMC

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021. May;71(3):209–249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. - DOI - PubMed
    1. Coldman A, Phillips N, Wilson C, Decker K, Chiarelli AM, Brisson J, Zhang B, Payne J, Doyle G, Ahmad R. Pan-Canadian study of mammography screening and mortality from breast cancer. J Natl Cancer Inst. 2014. Oct 1;106(11):dju261. doi: 10.1093/jnci/dju261. Erratum in: J Natl Cancer Inst. 2015 Jan;107(1):dju404 doi:10.1093/jnci/dju404. - DOI - PubMed
    1. Monsees BS. The Mammography Quality Standards Act. An overview of the regulations and guidance. Radiol Clin North Am. 2000. Jul;38(4):759–72. doi: 10.1016/s0033-8389(05)70199-8. - DOI - PubMed
    1. Loesch J Regulatory Compliance in Mammography. Radiol Technol. 2016. Mar-Apr;87(4):425M–442M; quiz 443M-444M. - PubMed
    1. Schünemann HJ, Lerda D, Quinn C, Follmann M, Alonso-Coello P, Rossi PG, Lebeau A, Nyström L, Broeders M, Ioannidou-Mouzaka L, Duffy SW, Borisch B, Fitzpatrick P, Hofvind S, Castells X, Giordano L, Canelo-Aybar C, Warman S, Mansel R, Sardanelli F, Parmelli E, Gräwingholt A, Saz-Parkinson Z; European Commission Initiative on Breast Cancer (ECIBC) Contributor Group. Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines. Ann Intern Med. 2020. Jan 7;172(1):46–56. doi: 10.7326/M19-2125. Epub 2019 Nov 26. - DOI - PubMed